mRNA |
masitinib |
GDSC1000 |
pan-cancer |
AAC |
-0.019 |
0.6 |
mRNA |
ML320 |
CTRPv2 |
pan-cancer |
AAC |
-0.021 |
0.6 |
mRNA |
CIL70 |
CTRPv2 |
pan-cancer |
AAC |
-0.027 |
0.6 |
mRNA |
selumetinib:GDC-0941 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.021 |
0.6 |
mRNA |
apicidin |
CTRPv2 |
pan-cancer |
AAC |
-0.018 |
0.6 |
mRNA |
LY-2183240 |
CTRPv2 |
pan-cancer |
AAC |
-0.018 |
0.6 |
mRNA |
foretinib |
GDSC1000 |
pan-cancer |
AAC |
-0.018 |
0.6 |
mRNA |
brivanib |
CTRPv2 |
pan-cancer |
AAC |
-0.02 |
0.6 |
mRNA |
tivozanib |
GDSC1000 |
pan-cancer |
AAC |
0.019 |
0.6 |
mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.021 |
0.6 |